La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Neuren Pharmaceuticals Résultats passés
Passé contrôle des critères 0/6
Informations clés
77.4%
Taux de croissance des bénéfices
75.4%
Taux de croissance du BPA
| Pharmaceuticals Croissance de l'industrie | 31.2% |
| Taux de croissance des recettes | 79.7% |
| Rendement des fonds propres | 76.5% |
| Marge nette | 67.7% |
| Dernière mise à jour des bénéfices | 31 Dec 2023 |
Mises à jour récentes des performances passées
Recent updates
Pinning Down Neuren Pharmaceuticals Limited's (ASX:NEU) P/S Is Difficult Right Now
Aug 14
Here's Why We Think Neuren Pharmaceuticals (ASX:NEU) Might Deserve Your Attention Today
May 31Getting In Cheap On Neuren Pharmaceuticals Limited (ASX:NEU) Is Unlikely
May 03An Intrinsic Calculation For Neuren Pharmaceuticals Limited (ASX:NEU) Suggests It's 41% Undervalued
Apr 01Forecast: Analysts Think Neuren Pharmaceuticals Limited's (ASX:NEU) Business Prospects Have Improved Drastically
Mar 05Here's Why Neuren Pharmaceuticals (ASX:NEU) Has Caught The Eye Of Investors
Mar 02Neuren Pharmaceuticals Limited's (ASX:NEU) 51% Jump Shows Its Popularity With Investors
Dec 18Need To Know: Analysts Are Much More Bullish On Neuren Pharmaceuticals Limited (ASX:NEU) Revenues
Sep 02Calculating The Fair Value Of Neuren Pharmaceuticals Limited (ASX:NEU)
Aug 31This Just In: Analysts Are Boosting Their Neuren Pharmaceuticals Limited (ASX:NEU) Outlook for This Year
Mar 03Neuren Pharmaceuticals (ASX:NEU) Is In A Strong Position To Grow Its Business
Jan 07We Think Neuren Pharmaceuticals (ASX:NEU) Can Easily Afford To Drive Business Growth
Sep 06Companies Like Neuren Pharmaceuticals (ASX:NEU) Can Afford To Invest In Growth
May 31We're Not Worried About Neuren Pharmaceuticals' (ASX:NEU) Cash Burn
Feb 03Here's Why We're Not At All Concerned With Neuren Pharmaceuticals' (ASX:NEU) Cash Burn Situation
Aug 06We Think Neuren Pharmaceuticals (ASX:NEU) Can Easily Afford To Drive Business Growth
May 05Independent Non-Executive Chairman Patrick Donald Davies Just Bought 21% More Shares In Neuren Pharmaceuticals Limited (ASX:NEU)
Feb 19Have Insiders Been Selling Neuren Pharmaceuticals Limited (ASX:NEU) Shares This Year?
Jan 04
Ventilation des recettes et des dépenses
Ventilation des recettes et des dépenses
Comment Neuren Pharmaceuticals gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.
Historique des gains et des recettes
| Date | Recettes | Les revenus | Dépenses G+A | Dépenses de R&D |
|---|---|---|---|---|
| 31 Dec 23 | 232 | 157 | 6 | 0 |
| 30 Sep 23 | 155 | 106 | 5 | 0 |
| 30 Jun 23 | 78 | 55 | 4 | 0 |
| 31 Mar 23 | 47 | 28 | 4 | 0 |
| 31 Dec 22 | 15 | 0 | 3 | 0 |
| 30 Sep 22 | 9 | -3 | 3 | 0 |
| 30 Jun 22 | 3 | -7 | 3 | 0 |
| 31 Mar 22 | 3 | -7 | 3 | 0 |
| 31 Dec 21 | 3 | -8 | 2 | 0 |
| 30 Sep 21 | 2 | -10 | 2 | 0 |
| 30 Jun 21 | 1 | -12 | 2 | 0 |
| 31 Mar 21 | 1 | -11 | 2 | 0 |
| 31 Dec 20 | 1 | -9 | 2 | 0 |
| 30 Sep 20 | 1 | -8 | 2 | 0 |
| 30 Jun 20 | 0 | -8 | 2 | 0 |
| 31 Mar 20 | 0 | -9 | 2 | 0 |
| 31 Dec 19 | 0 | -11 | 2 | 0 |
| 30 Sep 19 | 7 | -6 | 2 | 0 |
| 30 Jun 19 | 14 | -1 | 2 | 0 |
| 31 Mar 19 | 14 | 1 | 2 | 0 |
| 31 Dec 18 | 14 | 3 | 2 | 0 |
| 30 Sep 18 | 7 | 3 | 2 | 0 |
| 30 Jun 18 | 1 | 3 | 1 | 0 |
| 31 Mar 18 | 1 | 3 | 2 | 0 |
| 31 Dec 17 | 1 | 3 | 2 | 0 |
| 30 Sep 17 | 2 | -2 | 2 | 0 |
| 30 Jun 17 | 3 | -8 | 2 | 0 |
| 31 Mar 17 | 3 | -10 | 2 | 0 |
| 31 Dec 16 | 3 | -12 | 2 | 0 |
| 30 Sep 16 | 2 | -14 | 2 | 0 |
| 30 Jun 16 | 0 | -15 | 3 | 0 |
| 31 Mar 16 | 1 | -14 | 3 | 0 |
| 31 Dec 15 | 2 | -13 | 3 | 0 |
| 30 Sep 15 | 2 | -11 | 3 | 0 |
| 30 Jun 15 | 3 | -9 | 3 | 0 |
| 31 Mar 15 | 3 | -9 | 3 | 0 |
| 31 Dec 14 | 3 | -8 | 3 | 0 |
| 30 Sep 14 | 3 | -10 | 2 | 0 |
| 30 Jun 14 | 3 | -12 | 2 | 0 |
| 31 Mar 14 | 4 | -11 | 2 | 0 |
| 31 Dec 13 | 5 | -10 | 2 | 0 |
| 30 Sep 13 | 5 | -9 | 3 | 0 |